By
Aaron Nicodemus2023-03-10T19:32:00
A South Carolina-based software company agreed to pay $3 million to the Securities and Exchange Commission (SEC) to settle claims it violated securities law by failing to disclose the true scope of a ransomware attack that affected 13,000 users.
Blackbaud disclosed details about a breach of customer personal information in July 2020 on its website and through direct contact with customers but claimed no bank account information or Social Security numbers had been exposed.
In August, the company made a similar disclosure to the SEC in a quarterly report. The company omitted material information about the attack, the SEC said in its order, namely that the hacker did in fact obtain the bank account information and Social Security numbers of some Blackbaud customers.
2024-02-02T19:01:00Z By Jeff Dale
Software company Blackbaud will be required to delete unnecessary data and boost cybersecurity as part of a proposed settlement with the Federal Trade Commission stemming from a 2020 data breach.
2023-10-24T22:21:00Z By Kyle Brasseur
BlackRock Advisors agreed to pay $2.5 million as part of a settlement with the Securities and Exchange Commission addressing allegations the firm inaccurately described investments a fund it advised made in a now-defunct film production company.
2023-10-16T21:16:00Z By Jeff Dale
Software company Blackbaud agreed to pay $49.5 million in a multistate settlement addressing charges related to a 2020 cyberattack that exposed the personal data of approximately 13,000 consumers.
2025-11-05T18:35:00Z By Oscar Gonzalez
Approximately $9 billion of potential shadow-banking flows tied to Iranian networks in 2024, according to a new analysis from FinCEN. The report highlights how illicit funds are making their way through financial institutions as they meet the requirements of the Bank Secrecy Act (BSA).
2025-10-31T18:52:00Z By Oscar Gonzalez
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
2025-10-30T19:59:00Z By Oscar Gonzalez
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
Site powered by Webvision Cloud